Sean A. Fletcher

Sean A. Fletcher

Auto-generated profile, based on publicly available information

Sean A. Fletcher

Department of Surgery (Urology Service) Memorial Sloan Kettering Cancer Center New York NY USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2019 in Cancer
Verified
Journal Article
Open access
PDF file
ACAlexander P. Cole
Alexander P. Cole
SFSean A. Fletcher
Sean A. Fletcher
SBSebastian Berg
Sebastian Berg
Junaid NabiJunaid Nabi
Junaid Nabi
BMBrandon A. Mahal
Brandon A. Mahal
MLMuhieddine Labban
Muhieddine Labban
Background: There are race‐based differences in bladder cancer survival. To better understand this phenomenon, this study was designed to assess the statistical contributions of tumor, treatment, and access variables to race‐based differences in survival. Methods: Data were extracted from the National Cancer Data Base on black and white adults with muscle‐invasive bladder cancer from 2004 to 2015. The impact of tumor, access, and treatment variables on differences in survival was inferred by the performance of sequential propensity score–weighted analyses in which black and white patients were balanced with respect to demographics and health status (comorbidities) tumor characteristics, treatment, and access‐related variables. The propensity score–weighted hazard of death (black vs white) was calculated after each iteration. Results: This study identified 44,577 patients with a median follow‐up of 77 months. After demographics and health status were balanced, black race was associated with 18% worse mortality (hazard ratio, 1.18; 95% confidence interval [CI], 1.12‐1.25; P < .001). Balancing by tumor characteristics reduced this to 16%, balancing by treatment reduced this to 10%, and balancing by access‐related variables resulted in no difference. Access‐related variables explained 40% (95% CI, 22.9%‐57.0%) of the excess risk of death in blacks, whereas treatment factors explained 35% (95% CI, 22.2%‐46.9%). The contribution of tumor characteristics was not significant. Conclusions: In the models, differences in survival for black and white patients with bladder cancer are best explained by disparities in access and treatment, not tumor characteristics. Access to care is likely a key factor in racial disparities in cancer.

1 May 2022 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
SFSean A. Fletcher
Sean A. Fletcher
TBTrinity J. Bivalacqua
Trinity J. Bivalacqua
OBOtis W. Brawley
Otis W. Brawley
MKMax Kates
Max Kates

12 June 2025 in BJU International
Verified
Journal Article
Closed access
SFSean A. Fletcher
Sean A. Fletcher
MAMark N. Alshak
Mark N. Alshak
SLSeoho Lee
Seoho Lee
NSNirmish Singla
Nirmish Singla
MHMisop Han
Misop Han
CPChristian P Pavlovich
Christian P Pavlovich

14 April 2020 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
DPDaniel Pucheril
Daniel Pucheril
SFSean A. Fletcher
Sean A. Fletcher
XCXi Chen
Xi Chen
DFDavid F. Friedlander
David F. Friedlander
ACAlexander P. Cole
Alexander P. Cole
MLMuhieddine Labban
Muhieddine Labban

13 March 2024 in The Prostate
Verified
Journal Article
Closed access
SFSean A. Fletcher
Sean A. Fletcher
MMMufaddal M. Mamawala
Mufaddal M. Mamawala
AHAlbert E. Holler
Albert E. Holler
YBYasin Bhanji
Yasin Bhanji
KMKatarzyna J. Macura
Katarzyna J. Macura
CPChristian P Pavlovich
Christian P Pavlovich

17 August 2025 in BJU International
Verified
Journal Article
Closed access
SFSean A. Fletcher
Sean A. Fletcher
KMKatarzyna J. Macura
Katarzyna J. Macura
CPChristian P Pavlovich
Christian P Pavlovich